MY116452A - Cephalosporin salts and injectable compositions - Google Patents

Cephalosporin salts and injectable compositions

Info

Publication number
MY116452A
MY116452A MYPI89000050A MYPI8900050A MY116452A MY 116452 A MY116452 A MY 116452A MY PI89000050 A MYPI89000050 A MY PI89000050A MY PI8900050 A MYPI8900050 A MY PI8900050A MY 116452 A MY116452 A MY 116452A
Authority
MY
Malaysia
Prior art keywords
salts
crystalline
injectable compositions
zwitterion
admixture
Prior art date
Application number
MYPI89000050A
Inventor
Murray Arthur Kaplan
Robert Alan Lipper
Kun Mao Shih
Susan D Boettger
Thomas W Hudyma
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/144,899 external-priority patent/US4910301A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY116452A publication Critical patent/MY116452A/en

Links

Landscapes

  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CRYSTALLINE SULFURIC, DI-NITRIC, MONO-HYDROCHLORIC, DI-HYDROCHLORIC, AND DI- AND SESQUI-ORTHOSPHOSPHORIC ACID ADDITION SALTS OF 7-[-(2-AMINOTHIAZOL-4-YL)--(Z)-METHOXYIMINO-ACETAMIDO]-3-[(1-METHYL-LPYRROLIDINIO) METHYL]-3-CEPHEM-4 CARBOXYLATE ARE STABLE EVEN AT ELEVATED TEMPERATURES. THE CRYSTALLINE SULFURIC ACID ADDITION SALT IS MADE BY FORMING AN ADMIXTURE OF (A) AT LEAST ONE MOLAR EQUIVALENT OF SULFURIC ACID WITH (B) ZWITTERION IN AN AMOUNT SO AS TO BE PRESENT IN THE ADMIXTURE AT A CONCENTRATION OF GREATER THAN 25 MILLIGRAMS/ML, CAUSING CRYSTALLIZATION, SEPARATING THE CRYSTALS, WASHING AND DRYING. THE CRYSTALLINE MONOHYDROCHLORIDE, DIHYDROCHLORIDE, AND ORTHOPHOSPHATE SALTS ARE PREPARED BY DISSOLVING THE ZWITTERION IN THE APPROPRIATE AMOUNT OF ACID, CAUSING CRYSTALLIZATION BY ADDING ACETONE AND ISOLATING THE CRYSTALS. PHYSICAL ADMIXTURES OF THE SALTS WITH CERTAIN BASES IN PROPORTIONS TO GIVE A PH RANGING FROM ABOUT 3.5 TO ABOUT 7 ON DILUTION WITH WATER PROVIDE INJECTABLE COMPOSITIONS ON DILUTION.
MYPI89000050A 1985-08-05 1989-01-16 Cephalosporin salts and injectable compositions MY116452A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05
US90108886A 1986-08-27 1986-08-27
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts

Publications (1)

Publication Number Publication Date
MY116452A true MY116452A (en) 2004-02-28

Family

ID=27386181

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89000050A MY116452A (en) 1985-08-05 1989-01-16 Cephalosporin salts and injectable compositions

Country Status (1)

Country Link
MY (1) MY116452A (en)

Similar Documents

Publication Publication Date Title
ES2012948A6 (en) Cefepime cephalosporin salts
MY102212A (en) Cephalosporin salts and injectable compositions.
SE8605063D0 (en) DERIVATIVES OF CYCLOHEXANE
JPS54132592A (en) 3,7-di-substituted-3-cephem-4-carboxylic acid derivative, its salt, and their preparation
ES8200697A1 (en) Novel ergoline derivatives, compositions containing them, their preparation and use as pharmaceuticals.
MC1498A1 (en) PROCESS FOR THE PREPARATION OF PYRIDYLIC COMPOUNDS HAVING ANTIHISTAMINIC ACTIVITY
SE8800036L (en) LYOPHILIZED OR FELLED COMBINATION CEFALOSPORIN SWITZERLAND AND SALT
MY116452A (en) Cephalosporin salts and injectable compositions
JPS5559195A (en) 3,7-disubstituted-2 or 3-cephem-4-carboxylic acid compound or its salt, their preparation, and preventives and remedies for microbism comprising them as active constituents
DE69032733D1 (en) Lyophilized dihydrochloride salt of 7- [alpha- (2-aminothiazol-4-yl) alpha (Z) methoxyiminoacetamide] -3 - [(1-methyl-1-pyrrolidinium) methyl] -3-cephem-4-carboxylic acid
US3270009A (en) Carbocyclic-substituted aliphatic cephalosporins
CA1128862A (en) Cephradine compositions and method
GB1162247A (en) Cephalosporanic Acid Derivatives and a Process for the Preparation thereof
GB1353508A (en) Aminoisoquinolines
JPS54117493A (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compound, its salt, its preparation, and preventives and remedies for microbism consisting mainly of them
FI860210A (en) Process for the preparation of 4- / 2- (imidazol-1-yl) ethylthio / benzoic acid derivatives useful as a drug
GB1317159A (en) Manufacture of cephalosporin compounds
GB1513322A (en) Heterocyclic ergoline derivatives
CH610329A5 (en) Process for the preparation of stable crystalline salts of cephalosporins
DK391883D0 (en) Be stated in. TO PREPARE A CRYSTALLIZED ACID ADDITION SALT OF 7- (2- (2-AMINO-4-THIAZOLYL) -2-METHOXYIMINOACETAMIDO) -2-CARBOXY-3- (2- (5,6-DIOXO-4-FORMYLMETHYL-1,4) 5,6-TETRAHYDRO-1,2,4-TRIAZIN-3-YL) -THIOVINYL-8-OXO-5-THIA-1-AZABICYCLO (4.2.0) -2-OCTEN (SYNISOMER, FORM E)
ES8607322A1 (en) Novel preparation of cephalosporin compound
GB1318690A (en) Recovery of cephalothin salts
JPS5549384A (en) Novel antibacterial compound
TH6467EX (en) Monohydrate and salvate of new antibiotic B-Lactam.
GB942876A (en) Improvements in or relating to piperidylidene-thiaxanthene